Uv C Hld Technology Articles & Analysis
8 news found
As new coronavirus variants continue to mutate and spread, the growth in demand for infection prevention solutions using UV-C light is projected to reach $18.94 billion by 2030, witnessing an annual growth rate of 59.7% from 2021 to 2030. Further fueling the demand is the rise in hospital acquired infections (HAIs) that globally cause more fatalities due to the increase in antibiotic resistance ...
As new coronavirus variants continue to mutate and spread, the growth in demand for infection prevention solutions using UV-C light is projected to reach $18.94 billion by 2030, witnessing an annual growth rate of 59.7% from 2021 to 2030. Further fueling the demand is the rise in hospital acquired infections (HAIs) that globally cause more fatalities due to the increase in antibiotic resistance ...
UV technology company Respiray has launched a wearable air purifier that disinfects up to 99% of airborne bacteria and viruses. The Estonian-based technology firm has created a 21st-century alternative to traditional and more intrusive facemasks. It’s a hybrid solution that is more than just a face mask alternative – it’s a personal air purifier that uses UV-C light to ...
DURHAM, N.C.--(BUSINESS WIRE)--A new device using advanced UVC light technology that eliminates pathogens from the soles of shoes now greets people as they enter and exit Ronald McDonald House (RMH) of Durham. The HealthySole PLUS unit, donated by Collier’s Medical Equipment and HealthySole, is the newest addition to a comprehensive infection prevention program at RMH to ensure patient and ...
The new mini™ UVC disinfection robot, jointly developed by BlueBotics and Engmotion, is a robust, industry-proven solution that disinfects as programmed every time. Based on proven mobile robot and UVC lamp technologies the mini™ UVC, jointly developed by BlueBotics and Engmotion, can be used alone or in a connected fleet to autonomously disinfect hospitals and other public buildings ...
On July 7, 2020, the U.S. Environmental Protection Agency (EPA) announced that EPA researchers are evaluating a number of commercially available products for potential long-lasting effectiveness against SARS-CoV-2, the novel human coronavirus that causes COVID-19. This research is being conducted at EPA’s Office of Research and Development's Center for Environmental Solutions and Emergency ...
A study recently published in the journal, Clinical Infectious Diseases, discovered azole-resistance markers in 75% of a small group of aspergillosis patients who had not previously been treated with an azole. The research was conducted by the University of Manchester working with colleagues in the United States. Aspergillosis is the disease cause by Aspergillus. According to the Centers ...
According to the Centers for Disease Control and Prevention (CDC) one out of every twenty hospital patients acquires an infection while being treated for another illness. To help combat this problem, the CDC’s Prevention Epicenter Program recently announced $10 million awarded to five medical centers to explore ways to reduce healthcare-associated infections (HAIs). Also this week the ...